Harrow (HROW) Current Deferred Tax Assets (2013 - 2014)
Harrow (HROW) posted quarterly Current Deferred Tax Assets of $30000.0 for Q4 2014, down 25.0% year-over-year from $40000.0 in Q4 2013, and down 25.0% quarter-over-quarter from $40000.0 in Q4 2013.
Harrow (HROW) Current Deferred Tax Assets (2013 - 2014) Analysis & Trends
Harrow's Current Deferred Tax Assets history runs 2 years deep, the most recent figure standing at $30000.0 for Q4 2014.
- In Q4 2014, Current Deferred Tax Assets fell 25.0% year-over-year to $30000.0; the TTM figure through Dec 2014 stood at $30000.0 (down 25.0% YoY), while the FY2014 annual figure was $30000.0, down 25.0% from the prior year.
- Current Deferred Tax Assets for Q4 2014 stood at $30000.0, down from $40000.0 in the prior quarter.
- The five-year high for Current Deferred Tax Assets was $40000.0 in Q4 2013, with the low at $30000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Harrow | 1.58 Bn | 1.49 Bn | 50.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 30,000.00 |
| Dec 31, 2014 | 30,000.00 |
| Dec 31, 2013 | 40,000.00 |
| Dec 31, 2013 | 40,000.00 |